EGFR and neoplasm: In summary, this study showed that EGFR-restricted CAR-T cells showed fairly good efficacy in cytoreducing the tumor mass following intratumoral injection; however, the absence of spreading into the systemic circulation could correlate with a poor response on any distant metastases [7].